Your browser doesn't support javascript.
loading
GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18.
Glienke, Wolfgang; Dragon, Anna Christina; Zimmermann, Katharina; Martyniszyn-Eiben, Alexandra; Mertens, Mira; Abken, Hinrich; Rossig, Claudia; Altvater, Bianca; Aleksandrova, Krasimira; Arseniev, Lubomir; Kloth, Christina; Stamopoulou, Andriana; Moritz, Thomas; Lode, Holger N; Siebert, Nikolai; Blasczyk, Rainer; Goudeva, Lilia; Schambach, Axel; Köhl, Ulrike; Eiz-Vesper, Britta; Esser, Ruth.
Afiliación
  • Glienke W; ATMP-GMP Development Unit, Institute of Cellular Therapeutics, Integrated Research and Treatment Center for Transplantation, Hannover Medical School, Hannover, Germany.
  • Dragon AC; Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany.
  • Zimmermann K; Division of Hematology/Oncology, Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
  • Martyniszyn-Eiben A; ATMP-GMP Development Unit, Institute of Cellular Therapeutics, Integrated Research and Treatment Center for Transplantation, Hannover Medical School, Hannover, Germany.
  • Mertens M; ATMP-GMP Development Unit, Institute of Cellular Therapeutics, Integrated Research and Treatment Center for Transplantation, Hannover Medical School, Hannover, Germany.
  • Abken H; Leibniz Institute for Immunotherapy, Div Genetic Immunotherapy, Regensburg, Germany.
  • Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Altvater B; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Aleksandrova K; Cellular Therapy Center, Institute of Cellular Therapeutics, Hannover Medical School, Hannover, Germany.
  • Arseniev L; Cellular Therapy Center, Institute of Cellular Therapeutics, Hannover Medical School, Hannover, Germany.
  • Kloth C; Division of Hematology/Oncology, Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
  • Stamopoulou A; Division of Hematology/Oncology, Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
  • Moritz T; Division of Hematology/Oncology, Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
  • Lode HN; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany.
  • Siebert N; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany.
  • Blasczyk R; Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany.
  • Goudeva L; Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany.
  • Schambach A; Division of Hematology/Oncology, Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
  • Köhl U; Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
  • Eiz-Vesper B; ATMP-GMP Development Unit, Institute of Cellular Therapeutics, Integrated Research and Treatment Center for Transplantation, Hannover Medical School, Hannover, Germany.
  • Esser R; Cellular Therapy Center, Institute of Cellular Therapeutics, Hannover Medical School, Hannover, Germany.
Front Immunol ; 13: 839783, 2022.
Article en En | MEDLINE | ID: mdl-35401506
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Interleucina-18 Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Interleucina-18 Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania